📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Jindal Stainless Reports Capacity Rationalisation and Margin Pressure Due to Middle East Crisis
Jindal Stainless Limited (JSL) has disclosed that the Middle East war crisis is significantly impacting its operations due to a shortage of essential industrial gases like propane, LPG, and natural gas. Unlike traditional steelmakers, JSL's scrap-based production route relies heavily on these external fuels, forcing the company to operate its plants at rationalised capacity. Additionally, global shipping disruptions are causing vessel diversions and cargo delays, which are expected to increase costs and compress margins. The company is currently seeking government intervention for prioritized fuel allocation to mitigate further cascading effects on the industry.
Key Highlights
Plants are currently operating at rationalised capacity due to fuel availability constraints.
Heavy reliance on external propane, LPG, and natural gas makes JSL more vulnerable than conventional blast-furnace steelmakers.
Global shipping disruptions are leading to longer transit times and increased supply chain pressure.
Management warns of a direct negative impact on profit margins and potential cascading industry effects.
The company is awaiting government clarity on fuel allocation percentages to optimize future operations.
💼 Action for Investors
Investors should exercise caution as reduced capacity and higher logistics costs are likely to impact the upcoming quarterly earnings. Monitor government announcements regarding fuel allocation and the duration of shipping disruptions for signs of operational recovery.
JSLL Dehradun Hospital Receives NABH Accreditation Valid Until January 2029
Jeena Sikho Lifecare Limited (JSLL) has successfully secured the National Accreditation Board for Hospitals & Healthcare Providers (NABH) certification for its Dehradun facility. This accreditation specifically covers Panchakarma services at the Jakhan, Dehradun location and is valid until January 05, 2029. While this does not represent a physical expansion or capacity increase, it validates the company's adherence to high-quality healthcare standards and patient safety. Such certifications are crucial for building brand trust and potentially qualifying for government and insurance empanelments in the future.
Key Highlights
Awarded NABH accreditation for Dehradun Hospital (Jakhan) specifically for Panchakarma services.
The certification (No. AH-2026-0429) is valid for approximately three years until January 05, 2029.
Signifies adherence to nationally recognized standards for quality healthcare delivery and patient safety.
The accreditation occurred in the ordinary course of business and does not involve immediate capacity enhancement.
💼 Action for Investors
This is a positive development for long-term brand equity and service quality assurance. Investors should monitor if this accreditation leads to higher patient footfall or new insurance tie-ups for the Dehradun facility.
Jindal Stainless Targets 4.2 MTPA Capacity; Reports ₹418Bn LTM Revenue
Jindal Stainless Limited (JSL) has released an updated corporate presentation highlighting its position as India's largest stainless steel producer with a current capacity of 3 MTPA, scaling to 4.2 MTPA. For the LTM ending December 31, 2025, the company reported consolidated net revenue of approximately ₹418 billion and EBITDA of ₹52 billion. JSL maintains a very healthy balance sheet with a Net Debt to EBITDA ratio of 0.7x and Net Debt to Equity of 0.2x. The company is well-positioned to capture growth from India's projected 8-9% CAGR in stainless steel consumption through FY25.
Key Highlights
Current stainless steel capacity of 3 MTPA with a clear roadmap to reach 4.2 MTPA.
Reported LTM consolidated net revenue of ~₹418 billion and EBITDA of ~₹52 billion.
Robust leverage metrics with Net Debt/Equity at 0.2x and Net Debt/EBITDA at 0.7x.
Diversified sector exposure with Process (31%) and Architecture/Building (27%) as lead segments.
Ranked as the #5 global stainless steel producer excluding China, offering over 120 grades.
💼 Action for Investors
Investors should consider JSL a strong play on Indian infrastructure growth given its dominant market position and low leverage. The planned capacity expansion to 4.2 MTPA provides a clear medium-term growth catalyst.
JSL Partners with Indian Railways for India's First Stainless Steel Salt Container
Jindal Stainless Limited (JSL) has developed a specialized 20-foot stainless steel container for salt transport in partnership with Indian Railways. These containers offer a payload capacity of 33.0 metric tonnes and a lifespan of 15-20 years, which is 6-7 times longer than conventional alternatives. By replacing 100 road trailers with a single 48-wagon rake carrying 3,300 MT, the solution significantly reduces CO2 emissions and maintenance costs. This prototype aligns with RDSO specifications and positions JSL to capture a larger share of the growing bulk commodity logistics market.
Key Highlights
First-of-its-kind stainless steel salt container with 33.0 MT payload capacity and 3.0 MT tare weight.
Expected lifespan of 15-20 years, roughly 6-7 times longer than containers made of conventional materials.
A single rake of 96 containers carries 3,300 MT, equivalent to the capacity of 100 road trailers.
Uses SS 304 and JT Grade (N7) steel to provide superior corrosion resistance in chloride-rich environments.
Developed in accordance with RDSO specifications, targeting the expanding Indian container market.
💼 Action for Investors
Investors should view this as a positive step toward diversifying JSL's product portfolio into high-margin, specialized logistics solutions. Watch for commercial orders from Indian Railways as a catalyst for volume growth in the transport segment.
Jeena Sikho Lifecare Approves Q3 FY26 Unaudited Financial Results
Jeena Sikho Lifecare Limited (JSLL) has officially approved its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The board meeting was held on February 7, 2026, and concluded with the submission of the limited review report by statutory auditors. This announcement confirms the company's adherence to SEBI Listing Regulations 30 and 33. Investors should now focus on the detailed financial tables to assess the company's performance in the wellness and lifecare sector.
Key Highlights
Board approved unaudited standalone and consolidated results for the quarter ended December 31, 2025.
Statutory Auditors issued a Limited Review Report for the nine-month period ending December 2025.
The board meeting was conducted efficiently, starting at 04:05 P.M. and concluding at 04:35 P.M.
Compliance maintained under Regulation 30 and 33 of SEBI (LODR) Regulations, 2015.
💼 Action for Investors
Investors should analyze the detailed financial statements for revenue growth and EBITDA margins once the full report is accessed. Monitor the stock for any price volatility following the earnings release.
JSLL Q3 FY26 Results: Revenue Up 92% YoY, PAT Surges 405% to ₹66.73 Crore
Jeena Sikho Lifecare Limited (JSLL) delivered exceptional Q3 FY26 performance, with revenue growing 92% YoY to ₹221.66 crore. Profitability saw a massive boost as PAT surged 405% YoY to ₹66.73 crore, supported by EBITDA margins expanding from 26% to 45%. The growth was driven by a 247% YoY increase in OPD patient volumes and an 84% rise in IPD volumes. The company is aggressively expanding with 475+ beds in the pipeline, bringing total capacity towards 2,800 beds.
Key Highlights
Revenue from operations increased 92% YoY to ₹221.66 crore in Q3 FY26.
PAT skyrocketed 405% YoY to ₹66.73 crore with PAT margins reaching 30%.
EBITDA margins expanded significantly to 45% compared to 26% in Q3 FY25.
OPD, COD, and Video-Call patient volumes grew 247% YoY to 4.34 lakhs.
Current operational capacity is 2,290 beds with 475+ additional beds under development.
💼 Action for Investors
Investors should view the massive margin expansion and volume growth as a sign of high operational leverage and scalability. The company's transition to the mainboard and its aggressive bed expansion pipeline make it a strong growth candidate in the Ayurvedic healthcare sector.
Jeena Sikho Lifecare Approves Q3 FY26 Unaudited Standalone and Consolidated Financial Results
Jeena Sikho Lifecare Limited (JSLL) has announced its financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved both standalone and consolidated unaudited results during their meeting on February 7, 2026. The filing includes the Limited Review Report from statutory auditors, ensuring regulatory compliance under SEBI guidelines. Investors should now focus on the detailed financial statements to evaluate the company's growth and margin performance in the healthcare sector.
Key Highlights
Board approved unaudited standalone and consolidated financial results for the quarter ended Dec 31, 2025.
Statutory auditors provided a Limited Review Report for the nine-month period ending December 2025.
The board meeting was conducted and concluded within a 30-minute window (04:05 P.M. to 04:35 P.M.).
Compliance maintained as per Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
💼 Action for Investors
Investors should scrutinize the detailed profit and loss statements and balance sheet figures to assess the company's operational efficiency. Compare the Q3 results with previous quarters to identify any seasonal trends or growth momentum in the lifecare business.
Jeena Sikho Lifecare Board Approves Unaudited Q3 and Nine-Month FY26 Financial Results
Jeena Sikho Lifecare Limited (JSLL) held a board meeting on February 7, 2026, to approve its financial performance for the period ending December 31, 2025. The board cleared both standalone and consolidated unaudited results, supported by a limited review report from statutory auditors. This meeting marks the official release of Q3 FY26 performance data to the National Stock Exchange and BSE. Investors should now examine the detailed profit and loss statements to evaluate the company's operational efficiency and growth trajectory.
Key Highlights
Board approved unaudited standalone and consolidated financial results for the quarter ended December 31, 2025.
Approval granted for the financial results covering the nine-month period ending December 31, 2025.
Statutory Auditors issued a limited review report on the submitted financial statements.
The board meeting was conducted efficiently, lasting 30 minutes from 4:05 P.M. to 4:35 P.M. IST.
💼 Action for Investors
Investors should review the detailed financial tables once published to analyze revenue growth and margin trends. Compare these results against previous quarters to determine if the company is maintaining its growth momentum in the lifecare sector.
Jeena Sikho Lifecare Commences Operations at Two New Hospitals in Siliguri and Bhagalpur
Jeena Sikho Lifecare Limited (JSLL) has officially commenced operations at two new hospital facilities in Siliguri, West Bengal, and Bhagalpur, Bihar, effective February 3, 2026. The Siliguri facility adds 35 beds and 29 rooms, while the Bhagalpur unit adds 25 beds and 18 rooms to the company's healthcare network. Both facilities occupy 10,000 sq. ft. each and include dedicated OPD services. This expansion follows through on proposals initiated in 2025, demonstrating the company's commitment to scaling its physical infrastructure in the Eastern region.
Key Highlights
Commenced operations at two new hospitals in West Bengal and Bihar on February 3, 2026
Siliguri facility features 35 beds, 29 rooms, and 3 OPDs across 10,000 sq. ft.
Bhagalpur facility features 25 beds, 18 rooms, and 2 OPDs across 10,000 sq. ft.
Total capacity addition of 60 beds and 47 rooms across the two new locations
Execution of expansion plans within approximately one year of initial proposal
💼 Action for Investors
Investors should view this as a positive operational milestone that will likely contribute to revenue growth in the coming quarters. Monitor the occupancy rates and the company's ability to scale these new centers profitably.
JSLL to Engage with 25+ Institutional Investors at Nuvama 21st India Conference
Jeena Sikho Lifecare Limited (JSLL) has scheduled a series of group meetings with over 25 prominent institutional investors and asset management companies on February 10, 2026. The meetings will take place during the Nuvama 21st India Conference at Hotel Grand Hyatt, Mumbai. Participating entities include high-profile names such as PPFAS Mutual Fund, Motilal Oswal AMC, UTI Mutual Fund, and Aditya Birla Sun Life. These interactions are intended to discuss the company's business based on publicly available information, potentially increasing institutional visibility.
Key Highlights
Scheduled meetings with 25+ institutional investors and mutual funds on February 10, 2026.
Participation from top-tier funds including PPFAS Mutual Fund, Motilal Oswal AMC, and UTI Mutual Fund.
Four distinct group meeting slots scheduled between 10:00 AM and 1:50 PM.
Interaction organized as part of the Nuvama 21st India Conference in Mumbai.
💼 Action for Investors
Investors should monitor for any post-conference analyst reports or increased institutional buying activity. The high level of interest from reputed funds suggests growing institutional confidence in the company's business model.
Jindal Stainless Q3 FY26: PAT Rises 27% YoY to ₹828 Cr; Sales Volume Up 11%
Jindal Stainless Limited (JSL) reported a strong Q3 FY26 with consolidated PAT growing 27% YoY to ₹828 crores and sales volumes increasing 11% to 0.65 million tonnes. The company maintained steady domestic demand across automotive, railways, and white goods sectors, despite global export headwinds and import pressures. Financial health remains robust with net debt reducing to ₹3,451 crores and a healthy net debt-to-EBITDA ratio of 0.67. Management reaffirmed its EBITDA per tonne guidance of ₹19,000-₹21,000, having achieved ₹21,300 in the first nine months of the fiscal year.
Key Highlights
Consolidated EBITDA grew 17% YoY to ₹1,408 crores with a 9M average EBITDA per ton of ₹21,300.
Sales volume reached 0.65 million tonnes in Q3, marking an 11% YoY growth driven by domestic demand.
Net debt significantly reduced to ₹3,451 crores, resulting in a low net debt-to-equity ratio of 0.18.
Board approved an interim dividend of ₹1 per share (50% of face value) for FY26 with a record date of Jan 29, 2026.
Renewable power utilization increased to 56% of total imported power at Jajpur and Hisar facilities.
💼 Action for Investors
Investors should view the steady volume growth and significant debt reduction as positive indicators of operational efficiency and financial discipline. Monitor the government's upcoming decisions on anti-dumping duties and QCO enforcement as they will be critical for long-term margin protection against imports.
JSLL Reports One-Year Disease-Free Cancer Care Success in Peer-Reviewed Ayush Journal
Jeena Sikho Lifecare Limited (JSLL) has published a clinical case report in the 'Ayush Journal of Integrative Oncology' documenting a successful outcome for a 53-year-old breast cancer survivor. The report highlights a one-year disease-free resolution of recurrent lymphadenopathy achieved through the company's proprietary Ayurvedic protocols and lifestyle modifications. Co-authored by the Managing Director and the R&D team, this publication provides evidence-based validation for JSLL's clinical practices. This move is intended to strengthen the company's credibility in the integrative oncology space and support its research-driven growth strategy.
Key Highlights
Published case report in 'Ayush Journal of Integrative Oncology' documents a one-year disease-free status for a post-mastectomy patient.
Clinical resolution was documented via PET-CT scans, providing objective evidence for the efficacy of the Ayurvedic interventions.
The publication was co-authored by Managing Director Acharya Manish Grover and JSLL's Department of Research and Development.
Treatment involved a combination of personalized Ayurvedic formulations, Panchakarma therapies, and a 'Circadian D.I.P. diet'.
The report reflects the company's commitment to advancing Ayurvedic research and evidence-based clinical practices.
💼 Action for Investors
Investors should view this as a positive step toward clinical validation of the company's treatments, which enhances brand trust and market positioning. Monitor for further R&D milestones that could drive long-term patient acquisition and revenue growth.
JSLL Approves AED 7.53 Million Unsecured Loan to International Subsidiary
Jeena Sikho Lifecare Limited (JSLL) has approved an unsecured loan of AED 7.53 million to its wholly-owned subsidiary, Jeena Sikho International LLC. The loan, to be disbursed in two tranches, carries an interest rate of 8.5% per annum with a tenure of five years to support the subsidiary's operational requirements. Separately, the company disclosed it has paid fines imposed by the NSE and BSE for past non-compliance with SEBI Regulation 29. This capital infusion suggests a focus on international expansion while the company works to strengthen its internal compliance systems.
Key Highlights
Approved an unsecured loan of AED 7.53 million to wholly-owned subsidiary Jeena Sikho International LLC
Loan features an interest rate of 8.5% per annum on a simple interest basis
The loan tenure is set for 5 years from the date of the first disbursement
Paid fines to NSE and BSE for non-compliance with Regulation 29 regarding board meeting intimations
Transaction is confirmed to be on an arm's length basis as a related party transaction
💼 Action for Investors
Investors should monitor the growth and revenue contribution of the international subsidiary following this capital infusion. Additionally, keep a watch on the company's future regulatory filings to ensure compliance issues are fully resolved.
Jindal Stainless Q3 FY26 PAT Jumps 27% YoY to ₹828 Cr; Sales Volume Up 11%
Jindal Stainless Limited (JSL) reported a strong financial performance for Q3 FY26, with consolidated PAT rising 27% YoY to ₹828 crore. Revenue grew 6% YoY to ₹10,518 crore, driven by an 11% increase in sales volumes to 650,000 MT. The company demonstrated significant deleveraging, reducing net debt to ₹3,451 crore from ₹3,991 crore in March 2025, resulting in a healthy Net Debt/EBITDA ratio of 0.67. Management maintains a positive outlook for Q4 FY26, citing strong demand in the railway, infrastructure, and automobile sectors, further supported by recent GST rate cuts.
Key Highlights
Consolidated PAT increased 27% YoY to ₹828 crore in Q3 FY26.
Sales volume grew 11% YoY to 650,000 MT, with domestic markets contributing 95% of Q3 volume.
Consolidated EBITDA rose 17% YoY to ₹1,408 crore, reflecting improved operational efficiency.
Net debt reduced by ₹540 crore over nine months to ₹3,451 crore as of December 2025.
Strong demand outlook in Railways driven by Vande Bharat sleeper trainsets and Metro projects.
💼 Action for Investors
Investors should view the strong volume growth and consistent debt reduction as positive indicators of JSL's market leadership and financial health. The stock remains a key beneficiary of India's infrastructure push and the shift toward stainless steel in railways and automobiles.
Jindal Stainless Q3 FY26 PAT Surges 27% YoY to ₹828 Crore; Sales Volume Up 11%
Jindal Stainless reported a strong performance for Q3 FY26, with consolidated PAT rising 27% YoY to ₹828 crore. Revenue grew 6% YoY to ₹10,518 crore, driven by an 11% increase in standalone sales volumes to 650,000 MT. The company maintained a healthy balance sheet with net debt reducing to ₹3,451 crore from ₹3,991 crore in March 2025. Management highlighted positive demand across infrastructure, railways, and automobiles, further supported by recent GST rate cuts.
Key Highlights
Consolidated PAT grew 27% YoY to ₹828 crore in Q3 FY26, while 9M FY26 PAT rose 23% to ₹2,350 crore
Standalone sales volume increased by 11% YoY to 650,000 MT, with domestic sales accounting for 95% of the mix
Consolidated EBITDA for Q3 FY26 stood at ₹1,408 crore, representing a 17% YoY growth
Net debt improved significantly, falling from ₹3,991 crore in March 2025 to ₹3,451 crore in December 2025
Net Debt/EBITDA ratio remains robust at 0.67x as of December 2025 compared to 0.86x in March 2025
💼 Action for Investors
Investors should view the strong volume growth and consistent debt reduction as positive indicators of operational efficiency. The company's high domestic exposure and positive outlook in the infrastructure and railway sectors suggest continued growth potential.
Jindal Stainless Q3 FY26 PAT Rises 27% YoY to ₹828 Cr; Net Debt Reduced to ₹3,451 Cr
Jindal Stainless Limited (JSL) reported a strong Q3 FY26 performance with consolidated PAT growing 27% YoY to ₹828 crore, supported by an 11% increase in sales volumes to 650,000 MT. While consolidated revenue saw a minor 3% sequential dip to ₹10,518 crore, EBITDA margins remained resilient, growing 17% YoY to ₹1,408 crore. The company significantly strengthened its balance sheet, reducing net debt to ₹3,451 crore from ₹3,991 crore in March 2025. Management maintains a positive outlook for Q4 FY26, citing strong domestic demand in the infrastructure and railway sectors.
Key Highlights
Consolidated PAT increased by 27% YoY to ₹828 crore in Q3 FY26.
Sales volume grew 11% YoY to 650,000 MT, with domestic sales contributing 95% of the total volume.
Net Debt reduced to ₹3,451 crore as of December 2025, down from ₹3,991 crore in March 2025.
Net Debt/EBITDA ratio improved significantly to 0.67x compared to 0.86x in March 2025.
9M FY26 consolidated PAT reached ₹2,350 crore, marking a 23% growth over the previous year.
💼 Action for Investors
Investors should take note of the company's strong deleveraging and robust domestic volume growth. The focus on high-growth sectors like Railways and Infrastructure, combined with a healthier balance sheet, makes JSL a strong contender in the metals space.
Jindal Stainless Q3 FY26 PAT Jumps 27% YoY to ₹828 Crore; Net Debt Reduces to ₹3,451 Crore
Jindal Stainless Limited (JSL) reported a strong Q3 FY26 performance with consolidated PAT rising 27% YoY to ₹828 crore, supported by an 11% YoY growth in standalone sales volumes. While revenue saw a marginal 3% sequential decline to ₹10,518 crore, EBITDA margins remained resilient with a 17% YoY increase in consolidated EBITDA to ₹1,408 crore. The company significantly strengthened its balance sheet, reducing net debt from ₹3,991 crore in March 2025 to ₹3,451 crore in December 2025. Management maintains a positive outlook for Q4 FY26, citing demand tailwinds from GST rate cuts and increased stainless steel adoption in railways and infrastructure.
Key Highlights
Consolidated PAT increased 27% YoY to ₹828 crore in Q3 FY26; 9M FY26 PAT rose 23% to ₹2,350 crore.
Standalone sales volume grew 11% YoY to 650,000 MT, with domestic sales dominating at 95% of the total mix.
Net Debt reduced to ₹3,451 crore as of December 2025, down from ₹3,991 crore in March 2025.
Net Debt/EBITDA ratio improved significantly to 0.67x compared to 0.86x in March 2025.
Consolidated EBITDA for Q3 FY26 stood at ₹1,408 crore, reflecting a 17% YoY growth and 1% QoQ growth.
💼 Action for Investors
Investors should take note of the consistent volume growth and aggressive deleveraging, which strengthens the company's financial position. The stock remains a strong proxy for India's infrastructure and railway modernization sectors, especially with the positive demand outlook for Vande Bharat trainsets.
Jindal Stainless Sets Jan 29 as Record Date for INR 1 Interim Dividend
Jindal Stainless Limited (JSL) has announced January 29, 2026, as the record date for its interim dividend for the financial year 2025-26. The company will pay a dividend of INR 1 per equity share, which has a face value of INR 2. Shareholders whose names appear in the register as of the record date will be eligible for the payout. The payment process is scheduled to be completed on or before February 19, 2026.
Key Highlights
Interim dividend of INR 1 per equity share declared for FY 2025-26
Record date for determining eligibility is fixed as January 29, 2026
Dividend payment to be completed by February 19, 2026
Face value of the equity shares stands at INR 2 each
💼 Action for Investors
Investors seeking to qualify for the dividend should ensure they purchase or hold the stock before the ex-dividend date. This payout reflects the company's commitment to sharing profits with its shareholders.
JSL Q3 PAT Rises 7.6% YoY to ₹666 Cr; Announces ₹1 Interim Dividend
Jindal Stainless Limited (JSL) reported a steady Q3 FY26 performance with standalone Profit After Tax (PAT) reaching ₹665.85 crore, a 7.6% increase year-on-year. While revenue saw a slight sequential dip to ₹10,632 crore, operating margins improved to 10.38% from 9.74% in the preceding quarter. The board has declared an interim dividend of ₹1 per share (50% of face value) with a record date of January 29, 2026. Furthermore, the company continues to deleverage, with its debt-to-equity ratio improving to 0.24.
Key Highlights
Standalone Net Profit increased to ₹665.85 crore in Q3 FY26 from ₹618.64 crore in Q3 FY25.
Operating margin expanded to 10.38% in the current quarter compared to 9.74% in Q2 FY26.
Declared an interim dividend of ₹1 per equity share (50% of face value) for FY 2025-26.
Debt-to-equity ratio improved significantly to 0.24 from 0.33 in the year-ago period.
Re-appointed three Independent Directors, including Dr. Aarti Gupta, for a second three-year term.
💼 Action for Investors
Investors should take note of the improving operating margins and consistent debt reduction, which strengthen the company's financial profile. The stock remains a healthy pick for long-term exposure to the stainless steel sector, supported by regular dividend payouts.
Jindal Stainless Q3FY26 PAT Rises 26.6% to ₹828 Cr; Declares ₹1 Interim Dividend
Jindal Stainless Limited (JSL) reported a robust Q3 FY26 with consolidated PAT growing 26.6% Y-o-Y to INR 828 crore, driven by a 10.6% increase in sales volumes. Despite global export headwinds and a surge in low-priced imports from China and ASEAN, the company maintained its market share by focusing on the domestic market, which now accounts for 94.6% of total sales. Financial health remains strong with a low net debt-to-equity ratio of 0.18x and a consolidated EBITDA growth of 16.6%. The board also declared an interim dividend of INR 1 per share (50% of face value).
Key Highlights
Consolidated PAT surged 26.6% Y-o-Y to INR 828 crore, while EBITDA rose 16.6% to INR 1,408 crore.
Sales volume grew by 10.6% Y-o-Y to 6,49,857 tonnes, supported by demand from automotive and infrastructure sectors.
Net debt stands at a healthy INR 3,451 crore with a very low net debt-to-equity ratio of 0.18x.
Domestic sales mix increased to 94.6% as the company strategically pivoted away from subdued export markets.
Declared an interim dividend of INR 1 per share with a record date of January 29, 2026.
💼 Action for Investors
Investors should view the strong volume growth and margin expansion positively, especially given the challenging import environment. The company's low leverage and strategic entry into high-value segments like defense provide long-term growth visibility.